Terms: = Kidney tumors AND AKT2, PKBBETA, 208, ENSG00000105221, RAC-BETA, P31751, PRKBB AND Treatment
44 results:
1. Multiple factors influence decision making for the surgical treatment in patients with renal cell carcinoma.
Kröger Dahlin BI; Hlodan J; Ghaffarpour R; Ljungberg B
Scand J Urol; 2024 Feb; 59():26-30. PubMed ID: 38358280
[TBL] [Abstract] [Full Text] [Related]
2. An Updated Systematic Review and Meta-Analysis on the Technical, Oncologic, and Safety Outcomes of Microwave Ablation in Patients with Renal Cell Carcinoma.
Wu J; Sami S; Lajkosz K; Kishibe T; Ordon M
J Endourol; 2023 Dec; 37(12):1314-1330. PubMed ID: 37819699
[No Abstract] [Full Text] [Related]
3. Real-world effectiveness of nivolumab and subsequent therapy in Japanese patients with metastatic renal cell carcinoma (POST-NIVO study): 36-month follow-up results of a clinical chart review.
Yonese J; Hinata N; Masui S; Nakai Y; Shirotake S; Takeuchi A; Inamoto T; Nozawa M; Ueda K; Etsunaga T; Osawa T; Uemura M; Kimura G; Numakura K; Yamana K; Miyake H; Fukasawa S; Morishima N; Ito H; Uemura H
Int J Urol; 2023 Sep; 30(9):762-771. PubMed ID: 37248753
[TBL] [Abstract] [Full Text] [Related]
4. Cumulative sum analysis (CUSUM) for evaluating learning curve (LC) of robotic-assisted laparoscopic partial nephrectomy (RALPN).
Al-Nader M; Radtke JP; Püllen L; Darr C; Kesch C; Hess J; Krafft U; Hadaschik BA; Harke N; Mahmoud O
J Robot Surg; 2023 Oct; 17(5):2089-2098. PubMed ID: 37213028
[TBL] [Abstract] [Full Text] [Related]
5. Small Bowel Lipomatosis: An Unusual Radiological Finding in Patients With Renal Cell Cancer on Pazopanib.
Sharma A; Lakhani A; Ghosh-Ray S; Alam S; Padhani A; Gogbashian A; Nathan P
Anticancer Res; 2023 Feb; 43(2):789-793. PubMed ID: 36697087
[TBL] [Abstract] [Full Text] [Related]
6. Biodistribution and dosimetry for combined [
Delker A; Schleske M; Liubchenko G; Berg I; Zacherl MJ; Brendel M; Gildehaus FJ; Rumiantcev M; Resch S; Hürkamp K; Wenter V; Unterrainer LM; Bartenstein P; Ziegler SI; Beyer L; Böning G
Eur J Nucl Med Mol Imaging; 2023 Apr; 50(5):1280-1290. PubMed ID: 36629878
[TBL] [Abstract] [Full Text] [Related]
7. Nivolumab plus cabozantinib versus sunitinib in first-line treatment for advanced renal cell carcinoma (CheckMate 9ER): long-term follow-up results from an open-label, randomised, phase 3 trial.
Motzer RJ; Powles T; Burotto M; Escudier B; Bourlon MT; Shah AY; Suárez C; Hamzaj A; Porta C; Hocking CM; Kessler ER; Gurney H; Tomita Y; Bedke J; Zhang J; Simsek B; Scheffold C; Apolo AB; Choueiri TK
Lancet Oncol; 2022 Jul; 23(7):888-898. PubMed ID: 35688173
[TBL] [Abstract] [Full Text] [Related]
8. Impact of MET status on treatment outcomes in papillary renal cell carcinoma: A pooled analysis of historical data.
Albiges L; Heng DYC; Lee JL; Walker S; Mellemgaard A; Ottesen L; Frigault MM; L'Hernault A; Wessen J; Choueiri T; Cancel M; Signoretti S
Eur J Cancer; 2022 Jul; 170():158-168. PubMed ID: 35640484
[TBL] [Abstract] [Full Text] [Related]
9. A Prospective, Randomized Trial Comparing the Outcomes of Open vs Laparoscopic Partial Nephrectomy.
Guglielmetti GB; Dos Anjos GC; Sawczyn G; Rodrigues G; Cardili L; Cordeiro MD; Neves LCO; Pontes Junior J; Fazoli A; Coelho RF; Srougi M; Nahas WC
J Urol; 2022 Aug; 208(2):259-267. PubMed ID: 35404109
[TBL] [Abstract] [Full Text] [Related]
10. Comparison of open versus minimally invasive surgery in the treatment of thoracolumbar metastases.
Ntilikina Y; Collinet A; Tigan LV; Fabacher T; Steib JP; Charles YP
Orthop Traumatol Surg Res; 2022 Jun; 108(4):103274. PubMed ID: 35331924
[TBL] [Abstract] [Full Text] [Related]
11. Role of Renin-Angiotensin System Blockers on BCG Response in Nonmuscle Invasive, High Risk Bladder Cancer.
Motterle G; Morlacco A; Giovannini G; Vecchiato E; Iafrate M; Calpista A; Prayer-Galetti T; Martino F; Dal Moro F; Novara G
Clin Genitourin Cancer; 2022 Aug; 20(4):e303-e309. PubMed ID: 35314138
[TBL] [Abstract] [Full Text] [Related]
12. Testicular ultrasound underestimates the size of small testicular masses: a radiologic-pathologic correlation study.
Schwen ZR; Liu JL; Gabrielson AT; Patel HD; Gupta M; Rowe SP; Herati AS; Pierorazio PM
World J Urol; 2021 Sep; 39(9):3399-3405. PubMed ID: 33710425
[TBL] [Abstract] [Full Text] [Related]
13. A multicenter retrospective study of nivolumab monotherapy in previously treated metastatic renal cell carcinoma patients: interim analysis of Japanese real-world data.
Hinata N; Yonese J; Masui S; Nakai Y; Shirotake S; Tatsugami K; Inamoto T; Nozawa M; Ueda K; Etsunaga T; Osawa T; Uemura M; Kimura G; Numakura K; Yamana K; Miyake H; Fukasawa S; Ochi K; Kaneko H; Uemura H
Int J Clin Oncol; 2020 Aug; 25(8):1533-1542. PubMed ID: 32519026
[TBL] [Abstract] [Full Text] [Related]
14. Analysis of the nuclear expression of pSer727-STAT3 as a prognostic factor in patients with clear cell renal carcinoma.
Lorente D; Arevalo J; Salcedo MT; Trilla E; de Torres I; Meseguer A; Morote J
Actas Urol Esp (Engl Ed); 2020 May; 44(4):245-250. PubMed ID: 32247519
[TBL] [Abstract] [Full Text] [Related]
15. Gender-based psychological and physical distress differences in patients diagnosed with non-metastatic renal cell carcinoma.
Ajaj R; Cáceres JOH; Berlin A; Wallis CJD; Chandrasekar T; Klaassen Z; Ahmad AE; Leao R; Finelli A; Fleshner N; Goldberg H
World J Urol; 2020 Oct; 38(10):2547-2554. PubMed ID: 31893313
[TBL] [Abstract] [Full Text] [Related]
16. Pre-hydration in cisplatin-based CCRT: Effects on tumour concentrations and treatment outcome.
Aalbersberg EA; Rossi MM; de Wit-van der Veen LJ; Walraven I; van den Heuvel MM; Sonke JJ; Belderbos JS; Vogel WV
Radiother Oncol; 2019 May; 134():30-36. PubMed ID: 31005221
[TBL] [Abstract] [Full Text] [Related]
17. Baseline Edmonton Symptom Assessment System and survival in metastatic renal cell carcinoma.
Graham J; Gingerich J; Lambert P; Alamri A; Czaykowski P
Curr Oncol; 2018 Aug; 25(4):e319-e323. PubMed ID: 30111978
[TBL] [Abstract] [Full Text] [Related]
18. Immunomodulation by Entinostat in Renal Cell Carcinoma Patients Receiving High-Dose Interleukin 2: A Multicenter, Single-Arm, Phase I/II Trial (NCI-CTEP#7870).
Pili R; Quinn DI; Hammers HJ; Monk P; George S; Dorff TB; Olencki T; Shen L; Orillion A; Lamonica D; Fragomeni RS; Szabo Z; Hutson A; Groman A; Perkins SM; Piekarz R; Carducci MA
Clin Cancer Res; 2017 Dec; 23(23):7199-7208. PubMed ID: 28939740
[No Abstract] [Full Text] [Related]
19. Results of the First Prospective Multi-institutional treatment Study in Children With Bilateral Wilms Tumor (AREN0534): A Report From the Children's Oncology Group.
Ehrlich P; Chi YY; Chintagumpala MM; Hoffer FA; Perlman EJ; Kalapurakal JA; Warwick A; Shamberger RC; Khanna G; Hamilton TE; Gow KW; Paulino AC; Gratias EJ; Mullen EA; Geller JI; Grundy PE; Fernandez CV; Ritchey ML; Dome JS
Ann Surg; 2017 Sep; 266(3):470-478. PubMed ID: 28795993
[TBL] [Abstract] [Full Text] [Related]
20. Discontinuing VEGF-targeted Therapy for Progression Versus Toxicity Affects Outcomes of Second-line Therapies in Metastatic Renal Cell Carcinoma.
De Velasco G; Xie W; Donskov F; Albiges L; Beuselinck B; Srinivas S; Agarwal N; Lee JL; Brugarolas J; Wood LA; Rha SY; Kollmannsberger C; North S; Kanesvaran R; Rini BI; Broom R; Yamamoto H; Kaymakcalan MD; Heng DYC; Choueiri TK
Clin Genitourin Cancer; 2017 Jun; 15(3):403-410.e2. PubMed ID: 28254206
[TBL] [Abstract] [Full Text] [Related]
[Next]
